Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial intelligence, shares what's next for the world of AI.

Demis Hassabis, CEO of Google DeepMind, hinted Tuesday evening that Veo 3, Google’s latest video generating model, could ...

Demis Hassabis cofounded DeepMind, the renowned AI lab acquired by Google in 2014. He is also a former chess prodigy and won the Nobel Prize for Chemistry.

This story is part of the 2025 TIME100. Read Jennifer Doudna’s tribute to Demis Hassabis here. Demis Hassabis learned he had won the 2024 Nobel Prize in Chemistry just 20 minutes before the ...

Former OpenAI researcher Daniel Kokotajlo claims the company's founders thwarted Google DeepMind CEO Demis Hassabis's plan to ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...

When Demis Hassabis won the Nobel Prize last year, he celebrated by playing poker with a world champion of chess. Hassabis loves a game, which is how he became a pioneer of artificial intelligence ...

Demis Hassabis at DeepMind’s headquarters in London on Nov. 3, 2022 James Day for TIME. Hassabis believes the wealth from AGI, if it arrives, should be redistributed.

Demis Hassabis is emerging as the face of Google's AI effort and will take the stage at this week's annual developer's conference, Google I/O, for the first time.